427 results match your criteria: "Mother and Child Hospital[Affiliation]"

Contribution of Gag and Protease to HIV-1 Phenotypic Drug Resistance in Pediatric Patients Failing Protease Inhibitor-Based Therapy.

Antimicrob Agents Chemother

April 2016

Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), Johannesburg, South Africa Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Protease inhibitors (PIs) are used as a first-line regimen in HIV-1-infected children. Here we investigated the phenotypic consequences of amino acid changes in Gag and protease on lopinavir (LPV) and ritonavir (RTV) susceptibility among pediatric patients failing PI therapy. The Gag-protease from isolates from 20 HIV-1 subtype C-infected pediatric patients failing an LPV and/or RTV-based regimen was phenotyped using a nonreplicativein vitroassay.

View Article and Find Full Text PDF

Background: Efavirenz, widely used as part of antiretroviral drug regimens in the treatment of paediatric human immunodeficiency virus infection, has central nervous system side effects. We describe four children presenting with serious, persistent central nervous system adverse events who were found to have elevated plasma efavirenz concentrations as a result of carrying CYP2B6 single nucleotide polymorphisms, known to play a role in the metabolism of EFV. None of the children had a CYP2B6 wildtype haplotype.

View Article and Find Full Text PDF

PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations.

J Natl Cancer Inst

March 2016

Affiliations of authors:CR-UK Department of Oncology, University of Cambridge, Strangeways Research Laboratory , Cambridge, UK (PDPP, HS, ED, PH, CB); Department of Preventive Medicine, Keck School of Medicine , USC/NorrisComprehensive Cancer Center, University of Southern California , CA (MPI, SAG, SJR); Peter MacCallum Cancer Centre, East Melbourne , Victoria , Australia (KA, AOCSG, DDB); Westmead Millennium Institute, Westmead Hospital , Sydney , Australia (AOCSG); The QIMR Berghofer Medical Research Institute , Brisbane , Australia (AOCSG); Gynaecology Research Unit, Hannover Medical School , Hannover , Germany (NB, TD); Radiation Oncology Research Unit, Hannover Medical School , Hannover , Germany (NB); Mother and Child Hospital , Minsk , Belarus (NB); Department of Health Science Research, Division of Epidemiology, Mayo Clinic , Rochester, MN (MSC, JMC, ELG); Department of Biostatistics, University of Kansas Medical Center , KS (BLF); Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London , London, UK (AGM, MW, UM); Clinics of Obstetrics and Gynaecology, Hannover Medical School , Hannover , Germany (PH); Department of Gynecological Oncology, Roswell Park Cancer Institute , Buffalo, NY (SL, SP, KO); Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center , Los Angeles, CA (JL, BYK); Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine , Stanford, CA (VM, WS, ASW); Department of Cancer Prevention and Control, Roswell Park Cancer Institute , Buffalo, NY (KBM, LSC); Department of Obstetrics and Gynecology, Duke University Medical Center , Durham, NC (OCAC); Department of Biochemistry and Molecular Biology, University of Melbourne , Melbourne, Victoria , Australia (DDB); Sir Peter MacCallum Department of Oncology, University of Melbourne , Melbourne, Victoria , Australia (DDB); Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK (DDB).

Mosaic truncating mutations in the protein phosphatase, Mg(2+)/Mn(2+)-dependent, 1D (PPM1D) gene have recently been reported with a statistically significantly greater frequency in lymphocyte DNA from ovarian cancer case patients compared with unaffected control patients. Using massively parallel sequencing (MPS) we identified truncating PPM1D mutations in 12 of 3236 epithelial ovarian cancer (EOC) case patients (0.37%) but in only one of 3431 unaffected control patients (0.

View Article and Find Full Text PDF
Article Synopsis
  • Neonates in NICUs are often prescribed various drugs, many of which lack comprehensive safety and efficacy data, especially for premature infants.
  • A study observed 192 neonates, revealing that nearly all were exposed to unlicensed or off-label drugs, with higher usage in those born before 28 weeks gestation.
  • Out of the drugs reported, 15 were identified as potentially harmful, with a significant percentage of infants being exposed to harmful excipients, indicating a need for better drug safety and efficacy data in this vulnerable population.
View Article and Find Full Text PDF

Qualitative study of barriers to cervical cancer screening among Nigerian women.

BMJ Open

January 2016

Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA Institute of Human Virology and Greenebaum Cancer Centre, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Objectives: To explore the barriers to cervical cancer screening, focusing on religious and cultural factors, in order to inform group-specific interventions that may improve uptake of cervical cancer screening programmes.

Design: We conducted four focus group discussions among Muslim and Christian women in Nigeria.

Setting: Discussions were conducted in two hospitals, one in the South West and the other in the North Central region of Nigeria.

View Article and Find Full Text PDF

Upper airway obstruction and hemoptysis due to a leech infestation in a child.

Arch Pediatr

January 2016

Pediatric Intensive Care Medicine, Mother and Child Hospital, Mohammed VI Teaching Hospital, Cadi Ayyad University, Medical School of Marrakesh, Marrakesh, Morocco.

This paper presents the case of a 12-year-old child who presented with an 8-day history of cough, respiratory distress, and hemoptysis. He was admitted first to the pediatric intensive care unit to reestablish hemodynamic and respiratory stability. The chest X-ray showed a bilateral alveolar-interstitial syndrome.

View Article and Find Full Text PDF

Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial.

JAMA

November 2015

Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York4Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York.

Importance: Advantages of using efavirenz as part of treatment for children infected with human immunodeficiency virus (HIV) include once-daily dosing, simplification of co-treatment for tuberculosis, preservation of ritonavir-boosted lopinavir for second-line treatment, and harmonization of adult and pediatric treatment regimens. However, there have been concerns about possible reduced viral efficacy of efavirenz in children exposed to nevirapine for prevention of mother-to-child transmission.

Objective: To evaluate whether nevirapine-exposed children achieving initial viral suppression with ritonavir-boosted lopinavir-based therapy can transition to efavirenz-based therapy without risk of viral failure.

View Article and Find Full Text PDF

Influence of Spirituality and Modesty on Acceptance of Self-Sampling for Cervical Cancer Screening.

PLoS One

June 2016

Department of Epidemiology and Public Health; Institute of Human Virology and Greenebaum Cancer Centre, School of Medicine, University of Maryland, Baltimore, Maryland, United States of America.

Introduction: Whereas systematic screening programs have reduced the incidence of cervical cancer in developed countries, the incidence remains high in developing countries. Among several barriers to uptake of cervical cancer screening, the roles of religious and cultural factors such as modesty have been poorly studied. Knowledge about these factors is important because of the potential to overcome them using strategies such as self-collection of cervico-vaginal samples.

View Article and Find Full Text PDF

Growth and Mortality Outcomes for Different Antiretroviral Therapy Initiation Criteria in Children Ages 1-5 Years: A Causal Modeling Analysis.

Epidemiology

March 2016

From the aCentre for Infectious Disease Epidemiology and Research, University of Cape Town, Cape Town, South Africa; bInstitute of Epidemiology and Public Health, University of Bordeaux, Bordeaux, France; cUniversity of Ghana Medical School, Accra, Ghana; dWits Reproductive Health and HIV Institute, Harriet Shezi Children's Clinic, Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Soweto, South Africa; eCentre de Prise en Charge de Recherche et de Formation Enfants, Abidjan, Côte d'Ivoire; fEmpilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital and University of the Witwatersrand, Johannesburg, South Africa; gYopougon University Hospital, Abidjan, Côte d'Ivoire; hAfrica Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa; iAlbert Royer Hospital, Dakar, Senegal; jLighthouse Trust Clinic, Kamuzu Central Hospital, Lilongwe, Malawi; kUniversity of North Carolina, Chapel Hill, NC; lFélix Houphouët Boigny University Hospital, Abidjan, Côte d'Ivoire; mMédecins Sans Frontiéres South Africa, CapeTown, South Africa; nKhayelitsha ART Programme, Khayelitsha, Cape Town, South Africa; oCharles de Gaulle University Hospital, Ouagadougou, Burkina Faso; pNewlands Clinic, Harare, Zimbabwe; qHospital du Tokoin, Lomé, Togo; rSinikithemba Clinic, McCord Hospital, Durban, South Africa; sMTCT-Plus Center, Abidjan, Côte d'Ivoire; tDesmond Tutu HIV Centre, Cape Town, South Africa; uInstitute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; vInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland; and wInserm, U897, Epidémiologie-Biostatistiques, Université Bordeaux, Bordeaux, France.

Background: There is limited evidence regarding the optimal timing of initiating antiretroviral therapy (ART) in children. We conducted a causal modeling analysis in children ages 1-5 years from the International Epidemiologic Databases to Evaluate AIDS West/Southern-Africa collaboration to determine growth and mortality differences related to different CD4-based treatment initiation criteria, age groups, and regions.

Methods: ART-naïve children of ages 12-59 months at enrollment with at least one visit before ART initiation and one follow-up visit were included.

View Article and Find Full Text PDF

Objective: In order to increase the number of mature oocytes usable for intracytoplasmic sperm injection (ICSI), we aimed to investigate the effect of co-culturing granulosa cells (GCs) on human oocyte maturation in vitro, the fertilization rate, and embryo development.

Methods: A total of 133 immature oocytes were retrieved and were randomly divided into two groups; oocytes that were cultured with GCs (group A) and oocytes that were cultured without GCs (group B). After in vitro maturation, only oocytes that displayed metaphase II (MII) underwent the ICSI procedure.

View Article and Find Full Text PDF

Tuberculosis in Pediatric Antiretroviral Therapy Programs in Low- and Middle-Income Countries: Diagnosis and Screening Practices.

J Pediatric Infect Dis Soc

March 2015

Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland Swiss Tropical and Public Health Institute, Basel, Switzerland University of Basel, Switzerland.

Background: The global burden of childhood tuberculosis (TB) is estimated to be 0.5 million new cases per year. Human immunodeficiency virus (HIV)-infected children are at high risk for TB.

View Article and Find Full Text PDF

Background: Allogeneic hematopoietic stem cell transplantation (alloHSCT) is a procedure with a high infection risk. Strict isolation of patients is the rule to prevent such condition.

Objective: We compared the occurrence of severe infections (bacteremia and invasive fungal infection, IFI) in children undergoing alloHSCT before and after the move to a new protected unit with decreases in isolation methods.

View Article and Find Full Text PDF

Reducing CD4 Monitoring in Children on Antiretroviral Therapy With Virologic Suppression.

Pediatr Infect Dis J

December 2015

From the *Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; †HIV/AIDS Department, World Health Organization, Geneva, Switzerland; ‡Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa; §Kheth'Impilo, Cape Town, South Africa; ¶Médecins Sans Frontières, Khayelitsha, South Africa; ‖McCord Hospital, Durban, South Africa; **Hlabisa HIV Program, South Africa; ††Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, University of the Witwatersrand, Johannesburg, South Africa; ‡‡Wits Reproductive Health and HIV Institute, University of Witwatersrand, Johannesburg, South Africa; §§Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; ¶¶Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South Africa; ‖‖Gugulethu HIV Program, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa; ***Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, Maryland; and †††Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.

Background: Ongoing CD4 monitoring in patients on antiretroviral therapy (ART) with viral suppression has been questioned. We evaluated the probability of CD4 decline in children with viral suppression and CD4 recovery after 1 year on ART.

Methods: We included children from 8 South African cohorts with routine HIV-RNA monitoring if (1) they were "responders" [HIV-RNA < 400 copies/mL and no severe immunosuppression after ≥1 year on ART (time 0)] and (2) ≥1 HIV-RNA and CD4 measurement within 15 months of time 0.

View Article and Find Full Text PDF

The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy.

J Virol Methods

October 2015

Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address:

Paired plasma and dried blood spots (DBS) from 232 South African HIV-infected children initiating antiretroviral therapy (ART) were genotyped for drug resistance mutations, most of who had prior exposure to ART for prevention-of-mother-to-child-transmission. Non-nucleoside reverse transcriptase inhibitor mutations were most commonly detected in both specimen types, particularly Y181C/I and K103N/S. Resistance interpretation concordance was achieved in 97% of pairs with seven children having mutations detected in DBS only.

View Article and Find Full Text PDF

Growth in Virologically Suppressed HIV-Positive Children on Antiretroviral Therapy: Individual and Population-level References.

Pediatr Infect Dis J

October 2015

From the *Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland; †School of Public Health and Family Medicine, University of Cape Town, South Africa; ‡Leuven Institute for Research on Information Systems, KU Leuven, Belgium; §Department of Paediatrics and Child Health, Red Cross War Memorial Children's Hospital, University of Cape Town, Cape Town, South Africa; ¶Wits Reproductive Health and HIV Institute (Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto), University of Witwatersrand, Johannesburg, South Africa; ‖Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa; **Empilweni Services and Research Unit (Rahima Moosa Mother and Child Hospital, Johannesburg) and University of Witwatersrand, Johannesburg, South Africa; ††Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa; ‡‡Médecins Sans Frontières (MSF) South Africa, Khayelitsha, Cape Town, South Africa; §§Sinikithemba Clinic, McCord Hospital, Johannesburg, South Africa; and ¶¶Kheth'Impilo, Cape Town, South Africa.

Background: Combination antiretroviral therapy (ART) suppresses viral replication in HIV-infected children. The growth of virologically suppressed children on ART has not been well documented. We aimed to develop dynamic reference curves for weight-for-age Z scores (WAZ) and height-for-age Z scores (HAZ).

View Article and Find Full Text PDF

Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012.

J Acquir Immune Defic Syndr

August 2015

*School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; †MMed Paeds and Child Health (UNZA), Centre for Infectious Disease Research in Zambia, Lusaka, Zambia; ‡Tygerberg Academic Hospital and Stellenbosch University, Cape Town, South Africa; §Lighthouse Trust Clinic, Lilongwe, Malawi; ‖Red Cross War Memorial Children's Hospital, Cape Town, South Africa; ¶School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa; #Wits Reproductive Health and HIV Institute (Wits RHI), University of the Witwatersrand, Johannesburg, South Africa; **Empilweni Services and Research Unit, Department of Paediatrics and Child Health, Rahima Moosa Mother and Child Hospital and University of the Witwatersrand, Johannesburg, South Africa; ††Médecins Sans Frontierès, Khayelitsha and School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa; ‡‡Gugulethu Community Health Centre and Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; §§Newlands Clinic, Harare, Zimbabwe; ‖‖Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; ¶¶McCord Hospital, Durban, South Africa; and ##Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Somkhele, South Africa.

Background: There are limited published data on the outcomes of infants starting antiretroviral therapy (ART) in routine care in Southern Africa. This study aimed to examine the baseline characteristics and outcomes of infants initiating ART.

Methods: We analyzed prospectively collected cohort data from routine ART initiation in infants from 11 cohorts contributing to the International Epidemiologic Database to Evaluate AIDS in Southern Africa.

View Article and Find Full Text PDF

Improvement in the Outcome of Invasive Aspergillosis in a Pediatric Hematology Department: A 10-Year Review.

J Pediatr Hematol Oncol

October 2015

*Institute of Pediatric Hematology and Oncology, Hospices Civils de Lyon, Claude Bernard Lyon I University ‡Malaria Research Unit, ICBMS, CNRS UMR 5246, University Lyon 1 †Medical Mycology and Parasitology Unit, IP2M §Department of Pediatric Radiology, Women-Mother and Child Hospital, Hospices Civils de Lyon, Lyon, France.

Background: Invasive aspergillosis (IA) is associated with a high mortality rate despite the introduction of new antifungal agents. Several therapeutic strategies have been proposed to improve mortality rates in IA, including combination of drugs.

Methods: Here, we report the outcome of treatments based on a combination of antifungal agents on IA, including voriconazole and liposomal amphotericin B, in a pediatric population from 2001 to 2010.

View Article and Find Full Text PDF

Metaphyseal bony outgrowths are a well-recognized feature of fibrodysplasia ossificans progressiva (FOP) phenotype, but its genuine frequency, topographic distribution, morphological aspect, and potential implications are not fully established. To better ascertain the frequency and characteristics of osteocartilaginous exostoses in FOP disease, we conducted a cross-sectional radiological study based on all the traceable cases identified in a previous comprehensive national research. Metaphyseal exostoses were present in all the 17 cases of FOP studied.

View Article and Find Full Text PDF

Studies have shown a low frequency of HIV-1 protease drug resistance mutations in patients failing protease inhibitor (PI)-based therapy. Recent studies have identified mutations in Gag as an alternate pathway for PI drug resistance in subtype B viruses. We therefore genotyped the Gag and protease genes from 20 HIV-1 subtype C-infected pediatric patients failing a PI-based regimen.

View Article and Find Full Text PDF

Training program for the management of two obstetric emergencies within a French perinatal care network.

Eur J Obstet Gynecol Reprod Biol

June 2015

Obstetrics and Gynecology Department, Saint Etienne University Hospital, Saint-Priest-en-Jarez, France; Jean Monnet University, Faculty of Medicine, Saint Etienne, France; EA 3065 Thrombosis Research Group, Jean Monnet University, Saint Etienne, France. Electronic address:

Objectives: To evaluate the effectiveness of an interdisciplinary team training program based on simulated scenarios and focusing on two obstetrical emergency situations: shoulder dystocia and complicated breech vaginal delivery (CBVD). These situations are rare, so there are few opportunities for real-life training, yet their competent and efficient management is crucial to minimizing the risks to mother and child.

Study Design: The target population for training comprised the 450 professionals working in the French regional perinatal care network ELENA.

View Article and Find Full Text PDF

6R-tetrahydrobiopterin treated PKU patients below 4 years of age: Physical outcomes, nutrition and genotype.

Mol Genet Metab

May 2015

Gastroenterology and Paediatric Nutrition Unit, Virgen del Camino Hospital, C/ De Irunlarrea 4, 31008, Pamplona, Spain. Electronic address:

Background And Aims: Phenylalanine-restricted diets have proven effective in treating phenylketonuria. However, such diets have occasionally been reported to hinder normal development. Our study aimed to assess whether treating 0-4-year-old phenylketonuric patients with 6R-tetrahydrobiopterin might prevent growth retardation later in life.

View Article and Find Full Text PDF

Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.

AIDS

June 2015

aGertrude H. Sergievsky Center, College of Physicians and Surgeons bDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York, USA cCentre for HIV and STIs, National Institute for Communicable Diseases dEmpilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa eICAP, Mailman School of Public Health, Columbia University, New York, New York, USA.

Background: Negative results on standard HIV antibody tests have been described among HIV-infected children suppressed on antiretroviral therapy (ART) started early in life. Here, we describe the frequency and predictors of this phenomenon in a well characterized cohort of treated children.

Methods: We selected samples from 103 HIV-infected children who started ART 14 months of age or less and from 122 children who started 6 months of age or less followed as part of two sequential clinical trials in Johannesburg, South Africa.

View Article and Find Full Text PDF

Posterior Reversible Encephalopathy Syndrome in a Child Stung by Androctonus mauretanicus Scorpion.

J Stroke Cerebrovasc Dis

June 2015

Pediatric Intensive Care Medicine Department, Mother and Child Hospital, Mohammed VI Teaching Hospital, Medical School of Marrakech, Cadi Ayyad University, Marrakech, Morocco.

Posterior reversible encephalopathy syndrome (PRES) after scorpion sting was very rarely reported in literature. This is an authenticated report of PRES occurring, in a 3-year-old previously healthy girl, as a complication of the Moroccan Androctonus mauretanicus sting. According to the available and recent data, we attempt to discuss the potential mechanisms leading to this neurologic disorder and to determine the possible cause-effect relationship between scorpion venom and its development.

View Article and Find Full Text PDF

Satisfaction with delivery care for mothers giving birth at medical facilities, particularly hospitals, affects birth place selection. Lao PDR faces high maternal and infant mortality, and the government had introduced the Maternal and Child Health Strategy to Xiengkhuang Province in 2009 to combat high maternal and infant mortality there. This study aimed to determine the levels of delivery care satisfaction among mothers who gave birth in hospitals and examine the associations between satisfaction and background factors.

View Article and Find Full Text PDF